U.S. investors, Big Pharma race to find new medicines in China
U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country's biopharma sector transforms.
You are not logged in so some information on this page has been withheld. To see more, please log in.
since
auto-detected in 9 stories
3 months ago
page 1 of 1